in this issue
Regions :: South America :: Brazil
Amyris Narrows Third-Quarter Loss, Secures Project Funding from Brazil
10:15 AM MDT | November 3, 2011 | Rebecca Coons
Synthetic biology firm Amyris (Emeryville, CA) posted a net loss of $44 million it its third fiscal quarter ended September, 30, compared with a loss of $62 million in the same year-ago period. Sales increased 50%, to $26 million. The company is ramping up production of farnesene, a 15-carbon molecule produced from plant-based sugars that can be used a platform chemical for producing fuels, polymers, and a number of specialty chemicals. "We have farnesene production underway and finishing operations in place for our squalane and diesel,” said...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee